Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Brahmi

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
La Revue Du Praticien|March 29, 2024
[Difficulties in developing drugs for rare cancers: the example of sarcomas]Mehdi Brahmi
La Revue Du Praticien|January 23, 2026
[Sarcoma: 10 key messages]Mehdi Brahmi
La Revue Du Praticien|May 30, 2024
[Living with… sarcoma]Mehdi Brahmi
Current Opinion in Oncology|June 17, 2020
Immunotherapy in sarcoma: combinations or single agents? In whom?Armelle Dufresne, Mehdi Brahmi
Current Opinion in Oncology|April 30, 2019
Immunotherapy of heterogenous sarcomas: questions and strategiesArmelle Dufresne, Alexandra Meurgey, Mehdi Brahmi
Current Opinion in Oncology|June 17, 2020
Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyondMehdi Brahmi, Hélène Vanacker, Armelle Dufresne
Current Treatment Options in Oncology|January 29, 2016
Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R AxisMehdi Brahmi, Armelle Vinceneux, Philippe A Cassier
European Journal of Cancer (Oxford, England : 1990)|November 28, 2016
European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomasJean-Yves Blay, Mehdi Brahmi, Isabelle Ray-Coquard
Bulletin Du Cancer|October 17, 2017
[Therapeutic targeting of Notch signaling in cancer]Mehdi Brahmi, Olivia Bally, Lauriane Eberst, et al.
Nature Reviews. Clinical Oncology|April 19, 2018
Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumoursArmelle Dufresne, Mehdi Brahmi, Marie Karanian, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
La Revue Du Praticien|March 29, 2024
[Difficulties in developing drugs for rare cancers: the example of sarcomas]Mehdi Brahmi
La Revue Du Praticien|January 23, 2026
[Sarcoma: 10 key messages]Mehdi Brahmi
La Revue Du Praticien|May 30, 2024
[Living with… sarcoma]Mehdi Brahmi
Current Opinion in Oncology|June 17, 2020
Immunotherapy in sarcoma: combinations or single agents? In whom?Armelle Dufresne, Mehdi Brahmi
Current Opinion in Oncology|April 30, 2019
Immunotherapy of heterogenous sarcomas: questions and strategiesArmelle Dufresne, Alexandra Meurgey, Mehdi Brahmi
Current Opinion in Oncology|June 17, 2020
Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyondMehdi Brahmi, Hélène Vanacker, Armelle Dufresne
Current Treatment Options in Oncology|January 29, 2016
Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R AxisMehdi Brahmi, Armelle Vinceneux, Philippe A Cassier
European Journal of Cancer (Oxford, England : 1990)|November 28, 2016
European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomasJean-Yves Blay, Mehdi Brahmi, Isabelle Ray-Coquard
Bulletin Du Cancer|October 17, 2017
[Therapeutic targeting of Notch signaling in cancer]Mehdi Brahmi, Olivia Bally, Lauriane Eberst, et al.
Nature Reviews. Clinical Oncology|April 19, 2018
Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumoursArmelle Dufresne, Mehdi Brahmi, Marie Karanian, et al.
Pageof 9